Lok-Beta Pharmaceuticals (India )Private Limited, a active private limited company, was established on 18 April 2002 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2002PTC135577. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.07 M.
It upholds a compliant status. Its leadership includes Sudhanshu Kumar Singh (Director), Hina Kiran (Director), Alok Awadhesh Kumar (Managing Director). Past directors included Satyakam Kiran Kashyap, Rina Singh, Hina Kiran. It holds ₹37.30 Cr open charges and ₹9.31 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 324 Corporate Centre Nirmallifew Style Lbs Marg Mulund(W), Mumbai, Maharashtra, 400080.
U24230MH2002PTC135577
135577
18 April 2002
₹1.00 Cr
₹3.07 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Lok-Beta Pharmaceuticals (India )Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhanshu Kumar Singh | Director | 22 Aug 2012 | Current |
| Hina Kiran | Director | 01 Oct 2014 | Current |
| Alok Awadhesh Kumar | Managing Director | 18 Apr 2002 | Current |
| Ashish Kumar | Director | 01 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 30 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 12 Aug 2020 | Past |
| Pramod Abcsdd | Director | 01 Apr 2022 | Past |
| Pramod Abcsdd | Director | 24 Aug 2012 | Past |
| Pramod Abcsdd | Director | 01 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lok-Beta Pharmaceuticals (India )Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 87.01% increase. The company also saw a substantial improvement in profitability, with a 16.92% increase in profit. The company's net worth moved up by a moderate rise of 4.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Lok-Beta Pharmaceuticals (India )Private had a promoter holding of 75.40% and a public holding of 24.60%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹372,960,000.00
₹93,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2022 | Axis Bank Limited | ₹2.24 Cr | Open |
| 22 Apr 2022 | Axis Bank Limited | ₹2.15 Cr | Open |
| 26 Mar 2021 | State Bank Of India | ₹2.40 Cr | Open |
| 17 Feb 2021 | Axis Bank Limited | ₹10.00 Cr | Open |
| 08 Jan 2021 | Axis Bank Limited | ₹1.24 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lok-Beta Pharmaceuticals (India )Private, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lok-Beta Pharmaceuticals (India )Private, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lok-Beta Pharmaceuticals (India )Private's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lok-Beta Pharmaceuticals (India )Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Lok-Beta Pharmaceuticals (India )Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Ashish Kumar was appointed as a Director was appointed as a Director on 01 Dec 2022 & has been associated with this company since 3 years . was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 2.24 Cr with Charge ID 100583548 was registered on 25 May 2022. was completed.
The activity A charge with Axis Bank Limited of Rs. 2.15 Cr registered on 22 Apr 2022 with Charge ID 100582327 was modified on 25 May 2022. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 2.15 Cr with Charge ID 100582327 was registered on 22 Apr 2022. was documented.
The CIN of Lok-Beta Pharmaceuticals (India )Private Limited is U24230MH2002PTC135577.
Lok-Beta Pharmaceuticals (India )Private Limited is headquartered at 324 Corporate Centre Nirmallifew Style Lbs Marg Mulund(W), Mumbai, Maharashtra, 400080.
Lok-Beta Pharmaceuticals (India )Private Limited was incorporated on 18 April 2002.
The current directors of Lok-Beta Pharmaceuticals (India )Private Limited are
The primary industry of Lok-Beta Pharmaceuticals (India )Private Limited is Manufacturing.
Lok-Beta Pharmaceuticals (India )Private Limited is unlisted.
The authorized capital of Lok-Beta Pharmaceuticals (India )Private Limited is ₹1.00 Cr, and the paid-up capital is ₹3.07 M.
The compliance status of Lok-Beta Pharmaceuticals (India )Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
PRIVATE_LIMITED.webp)
Company Details
+91-XXXXXXXXXX